HACARUS INC. will be implementing the following organizational changes as of July 1, 2022.
At HACARUS, we strive to provide our customers with quick and flexible solutions. To improve our customer experience, we will be changing our organizational structure to a department-based system. We are simultaneously strengthening our governance and security systems by establishing quality control and information systems divisions.
Oversees the development and sales of the “HACARUS Check” visual inspection system focusing on the manufacturing industry.
Oversees the development and sales of the “HACARUS MD” diagnosis support platform and the “HACARUS DD” drug discovery support system. This department also actively promotes joint research projects with other companies and universities.
Overseas Business Department
Promotes the development of HACARUS solutions outside Japan and fosters joint business projects with overseas companies.
Business Development Department
Launches and promotes new business with customers and business partners utilizing HACARUS’ technological capabilities.
Headquarters Address: 604-8151 Hashibenkeicho Nakagyo Ward, Kyoto, Japan
12th Hase Bldg. 5th floor Rm 227
Established: January 14, 2014
CEO: Kenshin Fujiwara
Capital: 100 million yen
Capital Stock: 1.3 billion yen
[Media Coverage & Inquiries]
If you are interested in contacting HACARUS INC., please contact our public relations manager. Feel free to contact us about this case or any other media coverage.